Cidara Therapeutics (CDTX) Financials

$221.38

$0.00 (0.00%)

As on 08-Jan-2026 09:30EDT

Market cap

$6,962 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

16.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	1.28	23.28	64.29	49.57	12.07
Cost of Revenue	128.34	84.88	36.76	0.14	0.19	68.02
Gross Profit	-135.83	1.28	-13.48	64.29	49.57	12.07
Operating Expenses	150.46	177.38	13.58	94.01	91.83	83.92
Operating Profit (EBIT)	-195.46	-176.10	-27.06	-29.72	-42.26	-71.85
Other Income	--	--	--	0.19	--	-0.26
Profit before Tax	-184.80	-170.29	-25.07	-29.53	-42.47	-72.11
Provision for Tax	--	--	0.02	0.27	1.44	0.26
Profit after Tax (Net Income)	-184.74	-169.83	-22.93	-29.80	-43.91	-72.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-29.80	-42.47	-74.87

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	422.39	163.31	-8.21	-14.44	21.57	10.72
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.42	1.93	7.82	20.53	19.74	11.15
Current Liabilities	95.84	49.55	67.42	41.40	34.02	38.56
Total Liabilities	614.49	214.80	67.03	47.49	75.33	60.42

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	75.83	4.06	6.18	2.39	3.63	3.23
Current Assets	442.82	210.74	60.86	45.09	71.70	57.19
Total Assets	614.49	214.80	67.03	47.49	75.33	60.42
Total Debt*	1.98	3.58	4.88	1.21	5.06	7.96
Net Current Assets	346.98	161.18	-6.56	15.12	37.68	18.63

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-176.53	-22.43	-28.47	-25.23	-54.41
Cash Flow from Investing Activities	--	-0.13	-0.51	-0.12	-0.04	-0.19
Cash from Financing Activities	--	337.06	25.98	-0.95	44.60	37.28
Net Cash Inflow / Outflow	--	--	--	-29.54	--	-17.32

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-14.04	-17.46	-5.06	-8.29	-13.62	-32.66
Cash EPS ($)	--	-17.43	-5.04	-7.95	-14.00	-32.53
Adjusted Book Value ($)	--	16.79	--	--	6.69	4.85
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-18.15	-4.95	-7.92	-7.83	-24.65
Free Cash Flow per Share ($)	--	-18.16	-5.06	-7.95	-7.84	-24.73

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-207.67	276.94	-444.53	-193.81	-211.35
ROE (%)	-65.50	-218.99	202.50	-835.29	-271.98	-297.06
ROA (%)	-44.99	-120.52	-40.05	-48.53	-64.69	-111.45
EBIT Margin (%)	--	-13,811.92	-116.22	-46.23	-85.24	-595.42
Net Margin (%)	--	-13,319.76	-98.49	-46.22	-88.58	-610.85
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	-0.95	-0.64	0.30	3.11	-0.42
EBIT Growth (%)	-340.88	-550.78	8.94	29.67	41.19	-72.20
Net Profit Growth (%)	-50.03	-640.60	23.05	32.13	39.11	-75.49
EPS Growth (%)	45.89	-2.45	0.39	0.39	0.58	-0.32
Book Value Growth (%)	53.43	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.54	-0.16	-0.09	-0.09	-0.06
Price / Book Value	16.48	1.60	-0.44	-0.19	0.19	0.41
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.64	-0.43	1.01	1.01	1.22	0.33
Close Price ($)	95.76	26.88	0.79	0.76	1.27	2.00
High Price ($)	99.00	27.44	2.10	1.41	3.15	4.45
Low Price ($)	10.14	0.63	0.59	0.40	1.10	1.30
Market Cap ($ Cr)	6,961.58	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.02	-0.59	-0.08	0.23	0.74
Short term debt to equity ratio	0.00	0.01	-0.16	-0.08	0.17	0.74
Current Ratio	4.62	4.25	0.90	1.09	2.11	1.48
Quick Ratio	4.62	--	0.81	1.09	2.18	--
Interest Coverage	--	--	--	-155.59	-199.32	-274.23

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	132.86	69.78	9.07	10.80	92.61
Asset Turnover	--	0.01	0.41	1.05	0.73	0.19
Receivable days	--	2,569.64	173.18	31.78	60.90	169.28
Inventory Days	--	26.24	30.29	-3,311.51	-5,011.08	-29.78
Payable days	--	15.88	25.93	3,509.47	5,671.04	17.33
Cash Conversion Cycle	--	2,580.00	177.54	-6,789.19	-10,621.21	122.16

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.